Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
3
0
0
NEUBASE THERAPEUT. DL-,01 Share · US64132K2015 · NBSE · A3EHBD (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NEUBASE THERAPEUT. DL-,01
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 87,99 %
Shares Float 3,3 M
Shares Outstanding 3,75 M
Company Profile for NEUBASE THERAPEUT. DL-,01 Share
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Company Data
Name NEUBASE THERAPEUT. DL-,01
Company NeuBase Therapeutics, Inc.
Symbol NBSE
Primary Exchange 
Frankfurt
Frankfurt
WKN A3EHBD
ISIN US64132K2015
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Todd P. Branning
Country United States of America
Currency EUR
Employees 0,0 T
Address 350 Technology Drive, 15219 Pittsburgh
IPO Date 2004-05-28
Stock Splits
| Date | Split |
|---|---|
| 15.06.2023 | 1:20 |
| 04.02.2019 | 1:20 |
ID Changes
| Date | From | To |
|---|---|---|
| 16.07.2019 | OHRP | NBSE |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | NBSE |
More Shares
Investors who hold NEUBASE THERAPEUT. DL-,01 also have the following shares in their portfolio:
